Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Calluna secures FDA orphan drug designation for CAL101 in IPF
CAL101 is a monoclonal antibody that targets the S100A4, a type of damage-associated molecular pattern (DAMP) protein. Credit: Julia Koblitz/Unsplash.
CAL101 is a monoclonal antibody that targets the S100A4, a type of damage-associated molecular pattern (DAMP) protein. Credit: Julia Koblitz/Unsplash.